One Health: from the ancient roots to the collaborative, multisectoral approach addressing shared health
Chairs: A. Nardini, M. Tinelli
09.30-09.50
From humans to the environment and back: One-health approaches to define the two-way transmission of AMR in highly anthropized settings
G. Corno
09.50-10.10
One Health and Antimicrobial Resistance: Aligning Knowledge and Action
C. Manaia
10.10-10.30
Discussion
10.30-11.00
AMIT Lecture
Chairs: C. Losasso, M. Tinelli
Epidemics, pandemics and syndemics: an evolutionary and ecological issue
T. Pievani
INTERACTIVE SESSION 2
11.00-12.30
From the revolution of penicillin to the optimization of antibiotic therapy
Chairs: R. Bruno, C.M. Mastroianni
Discussant: G. Antonelli
11.00-11.20
Genomics in clinical microbiology and its role in infectious diseases
G.M. Rossolini
11.20-11.40
PK/PD antibiotic treatment optimization to improve clinical outcomes in infectious diseases - PK/PD-based dose optimisation in challenging patient groups
D. Cattaneo
11.40-12.00
Innovative treatment algorithms for CRE infection: from KPC to MBL and beyond
M. Bassetti
12.00-12.30
Discussion
12.30-13.00
AMIT Lecture
Chairs: A. Castagna, D. Cereda
Reverse vaccinology 3.0: the artificial intelligence revolution to propel vaccine development
E. Andreano
13.00-14.00
Lunch
SESSION 3
14.00-15.20
Innovative solutions to tackle infectious disease
Chairs: A. Cattelan, M.K. Mikulska
14.00-14.20
Incentives for new antibacterials and approaches for phage therapies
M. Cavaleri
14.20-14.40
New frontiers in antifungal therapy: novel agents and clinical applications
A. Vena
14.40-15.00
The strategic framework to prevent and tackle high risk epidemic infections
E. Nicastri
15.00-15.20
Discussion
INTERACTIVE SESSION 4
15.20-17.10
Difficult to treat MDR pathogens
Chairs: M. Giannella, G.C. Marchetti
Discussant: F.G. De Rosa
15.20-15.40
Difficult to treat Pseudomonas aeruginosa infections in critically ill patients: navigating new therapeutic options
G. Tiseo
15.40-16.00
Difficult to treat Stenotrophomonas maltophilia infections in Immunocompromised patients: are we finally moving beyond TMP-SMX?
M. Ripa
16.00-16.20
Acinetobacter baumannii in critically ill patients: new questions and answers
A. Russo
16.20-16.40
Role of vaccines in preventing lung infections and MDR selection
A. Lombardi
16.40-17.10
Discussion
17.10-17.30
Conclusive remarks
A. Castagna, M. Tinelli
SESSION 5
09.00-10.20
Antimicrobial stewardship across hospital settings and community
Chairs: A. Callegaro, C. Tascini
09.00-09.20
The EU-JAMRAI-2 project addresses five interrelated areas of action
B. Davido
09.20-09.40
Screening for MDR pathogens in hospital setting: how and when?
M. Meschiari
09.40-10.00
Is antimicrobial stewardship feasible across community?
P. Anello
10.00-10.20
Discussion
SESSION 6
10.20-11.40
HIV prevention and therapy today and tomorrow
Chairs: P. Bonfanti, A. Gori
10.20-10.40
Reiventing oral therapy: why the pill still matters
C. Mussini
10.40-11.00
Living beyond the pill: the injectable Long Acting perspective
A. Antinori
11.00-11.20
Beyond ART: the promise of bNAbs
A. Castagna
11.20-11.40
Discussion
11.40-12.10
AMIT Lecture
Chairs: E.G. Bignami, S. Piconi
Enhanced sepsis care: from early detection to management in the critical care setting
M. Antonelli
SESSION 7
12.10-13.10
Emerging therapeutic options for prevention and treatment for Hepatitis B and Delta
Chairs: P.G. Giuri, M. Puoti
12.10-12.30
HBV
M.R. Brunetto
12.30-12.50
HDV
P. Lampertico
12.50-13.10
Discussion
13.10-14.10
Lunch
14.10-14.40
AMIT Lecture
Chairs: A. Bandera, C.S. Vismara
The forthcoming BBLI antibiotics in phase III
M. Falcone
SESSION 8
14.40-16.00
Update of incoming infections: prevention and treatment
Chairs: A. Cascio, A. Oliva
Chairs: S. Antinori
14.40-15.00
Cutting-edge strategies for treating Staphylococcus aureus infections
D.R. Giacobbe
15.00-15.20
Advances in Tuberculosis management
N. Riccardi
15.20-15.40
Sexually transmitted diseases: update of treatment
S. Nozza
15.40-16.00
Discussion
16.00-16.30
Conclusive remarks
A. Castagna, M. Tinelli
Organizing Secretariat and CME Provider Effetti srl via G.B. Giorgini 16, 20151 Milan (Italy)
Tel. +39 023343281 - www.effetti.it - www.makevent.it